Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High incidence of hyperventilation syndrome after COVID-19.
Taverne J, Salvator H, Leboulch C, Barizien N, Ballester M, Imhaus E, Chabi-Charvillat ML, Boulin A, Goyard C, Chabrol A, Catherinot E, Givel C, Couderc LJ, Tcherakian C. Taverne J, et al. Among authors: chabrol a. J Thorac Dis. 2021 Jun;13(6):3918-3922. doi: 10.21037/jtd-20-2753. J Thorac Dis. 2021. PMID: 34277081 Free PMC article. No abstract available.
Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation.
Salvator H, Berti E, Catherinot E, Rivaud E, Chabrol A, Nguyen S, Zemoura L, Cardot E, Tcherakian C, Couderc LJ; Foch Hospital Lung Immune Deficiencies Study Group. Salvator H, et al. Among authors: chabrol a. Eur Respir J. 2018 May 30;51(5):1701960. doi: 10.1183/13993003.01960-2017. Print 2018 May. Eur Respir J. 2018. PMID: 29650554 Free article. No abstract available.
Lorlatinib - Induced pulmonary arterial hypertension.
Chabrol A, Mayenga M, Hamid AM, Friard S, Salvator H, Doubre H, Fraboulet S, Metivier AC, Catherinot E, Rivaud E, Chaumais MC, Montani D, Couderc LJ, Tcherakian C. Chabrol A, et al. Lung Cancer. 2018 Jun;120:60-61. doi: 10.1016/j.lungcan.2018.03.023. Epub 2018 Mar 27. Lung Cancer. 2018. PMID: 29748016
Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center.
Goussault H, Salvator H, Catherinot E, Chabi ML, Tcherakian C, Chabrol A, Didier M, Rivaud E, Fischer A, Suarez F, Hermine O, Lanternier F, Lortholary O, Mahlaoui N, Devillier P, Couderc LJ. Goussault H, et al. Among authors: chabrol a. Respir Res. 2019 Dec 4;20(1):275. doi: 10.1186/s12931-019-1242-4. Respir Res. 2019. PMID: 31801528 Free PMC article.
COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics.
Mouren D, Goyard C, Catherinot E, Givel C, Chabrol A, Tcherakian C, Longchampt E, Vargaftig J, Farfour E, Legal A, Couderc LJ, Salvator H. Mouren D, et al. Among authors: chabrol a. Respir Med Res. 2021 May;79:100814. doi: 10.1016/j.resmer.2021.100814. Epub 2021 Feb 5. Respir Med Res. 2021. PMID: 33610911 Free PMC article. No abstract available.
Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire Survey.
Salvator H, Tcherakian C, Maillard N, Milin S, Bergeron A, Bondeelle L, Meignin V, Nguyen S, Souchet L, Guenounou S, Evrard SM, Rubio MT, Robin M, Sestili S, Brissot E, Fajac A, Catherinot E, Givel C, Chabrol A, Goyard C, Longchampt E, Chabi-Charvillat ML, Bernaudin JF, Couderc LJ. Salvator H, et al. Among authors: chabrol a. Chest. 2021 Nov;160(5):1783-1788. doi: 10.1016/j.chest.2021.05.056. Epub 2021 Jun 5. Chest. 2021. PMID: 34102143 No abstract available.
[Pulmonary complications of Chronic Granulomatous Disease].
Salvator H, Mahlaoui N, Suarez F, Marcais A, Longchampt E, Tcherakian C, Givel C, Chabrol A, Caradec E, Lortholary O, Lanternier F, Goyard C, Couderc LJ, Catherinot E. Salvator H, et al. Among authors: chabrol a. Rev Mal Respir. 2024 Feb;41(2):156-170. doi: 10.1016/j.rmr.2024.01.002. Epub 2024 Jan 24. Rev Mal Respir. 2024. PMID: 38272769 Review. French.
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: chabrol a. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
87 results